维普期刊资源整合服务平台（V6.5）

33篇 您的检索式：作者名="PODDA G"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	CD30 in normal and neoplastic cells显示文摘	CHIARLE R PODDA A PROLLA G	1999	Clin Immunol1999，90，2：	1
2	CD30 over express ion enhances negative selection in the thymus and mediates programmmed cell death via a Bcl-2 sensitive pathway显示文摘	Chiarle R Podda A Prolla G		0，，01：	1
3	Vereinfachtes Verfahren Zur Berechung von Tellerfedern显示文摘	Curti G Orlando M Podda G	1980	Draht1980，31，11：	1
4	Nonhydrated anion transfer from the aqueous to the organic phase: Enhancement of nucleophilic reactivity in phase-transfer catalysis显示文摘	Landini D Maia A Podda G	1982	J Org Chem1982，47，12：	1
5	Investigation on ESD-stressed GaN/InGaN-on-sapphire blue LED显示文摘	Meneghesso G Podda S Vanzi M	2001	Microelection Reliab2001，41，5：	1
6	Comparison of different pro- cedures to prepare platelet-rich plasma for studies of platelet aggrega- tion by light transmission aggregometry 显示文摘	Femia EA Pugliano M Podda G	2012	Platelets2012，23，1：	1
7	MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profile 显示文摘	Podda A Del Giudice G	2003	Expert Rev Vaccines2003，2，2：	1
8	Comparison of different pro- cedures to prepare platelet-rich plasma for studies of platelet aggrega- tion by light transmission aggregometry 显示文摘	Femia EA Pugliano M Podda G	2012	Platelets2012，23，1：	1
9	Investigation on ESD-stressed GaN/lnGaN-on-sapphire blue LEDs 显示文摘	MENEGHESSO G PODDA S VANZI M	2001	Microelectronics Reliability2001，41，910：	1
10	Abnormalities of homocysteine and B vitamins in the nephrotic syndrome 显示文摘	Podda GM Lussana F Moroni G	2007	Thromb Res2007，120，5：	1
11	Histological evaluation of bone reactions to aluminium oxide dental implants in man:a case report显示文摘	PODDA G SCARANO A	1996	Biomaterials1996，17，7：	1
12	Thyroid carcinoma after treatment for malignancies in childhood and adolescence: from diagnosis through follow-up显示文摘	Podda M G Terenziani M Gandola L	2014	Med Oncol2014，31，8：	1
13	MF59-adjuvanted vaccines:increased immunogenicity with an optimal safety profile显示文摘	Podda A Del Giudice G		0，，02：	1
14	MF59-adjuvanted vaccines:increased immunogenicity with an optimal safety profile显示文摘	Podda A Del Giudice G	2003	Exper Rev Vaccines2003，2，2：	1
15	Proteasome inhibition reduces superantigen-mediaed T cell activation and the severity of psoriasis in a SCID-hu mode显示文摘	Zollner TM Podda M Picn G	2002	J Clin Invest2002，109，5：	1
16	Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza显示文摘	Nicholson K G Colegate A E Podda A	2001	Lancet2001，357，9272：	1
17	Do procalcitonin algorithms modify mortality?显示文摘	Ferrari L Casella F Podda G M	2012	Arch Intern Med2012，172，2：	1
18	MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profile 显示文摘	Podda A Del Giudice G	2003	Expert Rev Vaccines2003，2，2：	1
19	MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profile显示文摘	Podda A Del-Giudice G	2003	Expert Rev Vaccines2003，2，2：	1
20	MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profile显示文摘	Podda A Del Gudice G	2003	Exper Rev Vaccines2003，2，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示